The Role of Microbiota in Pathogenesis of Dyslipidemia and Associated Metabolic Disorders

Dokazatel'naya gastroenterologiya
doi 10.17116/dokgastro20176229-34
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Media Sphere Publishing Group

Related search

Dyslipidemia in Metabolic Syndrome: An Overview of Lipoprotein- Related Disorders

International Journal of Cardiology and Lipidology Research
2017English

Role of Intestinal Microbiota Changes in Cardiovascular Diseases Pathogenesis

Zaporozhye Medical Journal
2019English

The Role of BDNF in the Pathogenesis of Neurological and Mental Disorders

Современные проблемы науки и образования (Modern Problems of Science and Education)
2018English

Insights Into the Role of Gut Microbiota in Obesity: Pathogenesis, Mechanisms, and Therapeutic Perspectives

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2018English

Gut Microbiota and the Pathogenesis of Insulin Resistance

Current Diabetes Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Synthesis, Activation and Deactivation of Glucocorticoids. The Biological Role of Cortisol in Metabolic Disorders

Obesity and Metabolism
Internal MedicineNutritionEndocrinologyPublic HealthEnvironmentalDieteticsOccupational HealthMetabolismDiabetes
2017English

The Role of Niacin in the Management of Dyslipidemia†

Journal of Clinical Lipidology
Internal MedicineNutritionCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2019English

The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer

Mediators of Inflammation
ImmunologyCell Biology
2017English

MeMbrane Disorder in Pathogenesis of the Major Risks of the Cardiovascular Death — Hypertention and dyslipideMia

The Bulletin of Contemporary Clinical Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy